Patent Yard Sign in
Expired Canadian patentCanada

Streptogramin derivatives, preparation and compositions containing them

CA 2376698 C · Owner: Barriere, Jean-Claude · Inventors: Ribeill, Yves; Achard, Daniel; Bacque, Eric

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention concerns derivatives of group A of streptogramins of general formula (I) wherein: R¿1? represents a halogen atom or an azido or thiocynato radical; R¿2? represents a hydrogen atom or a methyl or ethyl radical; R¿3? represents a hydrogen atom or the radical of an aliphatic, cycloaliphatic aromatic, araliphatic, heterocyclic or heterocylclylaliphatic ester capable of being substituted and the bond <u>---</u>represents a single bond (stereochemistry 27R) or a double bond and their salts when they exist.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 29, 2000 and granted May 14, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 29, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 29, 2000
GrantedMay 14, 2013
Term endedJune 29, 2020
Patent numberCA 2376698 C
Classification (IPC)C07K5/07 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedJune 29, 2000Patent grantedMay 14, 2013Term endedJune 29, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.